A multi-center phase II, open-label study to evaluate the pharmacokinetics of tacrolimus or cyclosporine [ciclosporin] when co-administered with adefovir dipivoxil 10 mg to patients post-liver transplantation

Trial Profile

A multi-center phase II, open-label study to evaluate the pharmacokinetics of tacrolimus or cyclosporine [ciclosporin] when co-administered with adefovir dipivoxil 10 mg to patients post-liver transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2006

At a glance

  • Drugs Adefovir dipivoxil (Primary)
  • Indications Hepatitis B; Liver transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 07 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top